Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 5:16 pm Purchase | 2025-06-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 796,558 6.240% | 796,558 (New Position) | Filing History |
| 2025-08-14 4:38 pm Purchase | 2025-06-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 1,234,596 9.990% | 10,257 (+0.84%) | Filing History |
| 2025-08-14 4:05 pm Purchase | 2025-06-30 | 13G | Unicycive Therapeutics, Inc. UNCY | BIOTECHNOLOGY VALUE FUND L P | 1,417,117 9.990% | 1,417,117 (New Position) | Filing History |
| 2025-08-12 4:05 pm Purchase | 2025-06-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Octagon Capital Advisors LP | 1,000,000 7.800% | 1,000,000 (New Position) | Filing History |
| 2025-05-15 4:56 pm Purchase | 2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY | RA CAPITAL MANAGEMENT L.P. | 1,328,578 9.900% | 176,566 (+15.33%) | Filing History |
| 2025-05-15 4:39 pm Purchase | 2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 1,224,339 9.990% | 136,424 (+12.54%) | Filing History |
| 2025-05-15 08:30 am Unchanged | 2025-03-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% | 0 (Unchanged) | Filing History |
| 2025-02-14 6:43 pm Purchase | 2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | RA CAPITAL MANAGEMENT L.P. | 1,152,012 9.900% | 104,775 (+10.00%) | Filing History |
| 2025-02-14 4:39 pm Purchase | 2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 1,147,317 9.990% | 195,073 (+20.49%) | Filing History |
| 2025-02-06 3:08 pm Unchanged | 2024-12-31 | 13G | Unicycive Therapeutics, Inc. UNCY | Walleye Capital LLC | 500,000 4.820% | 0 (Unchanged) | Filing History |
| 2024-12-20 4:32 pm Purchase | 2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 1,087,914 9.990% | 71,979 (+7.09%) | Filing History |
| 2024-12-20 4:31 pm Sale | 2024-12-19 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 300,902 2.760% | -487,882 (-61.85%) | Filing History |
| 2024-11-14 7:13 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Logos Global Management LP | 507,893 4.900% | 507,893 (New Position) | Filing History |
| 2024-11-14 7:01 pm Purchase | 2024-10-09 | 13G | Unicycive Therapeutics, Inc. UNCY | Vivo Opportunity Fund Holdings, L.P. | 6,096,173 9.990% | 100,000 (+1.67%) | Filing History |
| 2024-11-14 5:46 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | RA CAPITAL MANAGEMENT L.P. | 1,047,238 9.990% | 700,027 (+201.61%) | Filing History |
| 2024-11-14 5:05 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Great Point Partners, LLC | 952,243 9.990% | 96,343 (+11.26%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Nantahala Capital Management, LLC | 1,015,935 9.990% | 668,364 (+192.30%) | Filing History |
| 2024-11-14 4:53 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP | 788,784 7.760% | 576,608 (+271.76%) | Filing History |
| 2024-11-14 4:29 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | BIOTECHNOLOGY VALUE FUND L P | 1,047,123 9.990% | 700,101 (+201.74%) | Filing History |
| 2024-11-13 4:52 pm Purchase | 2024-09-30 | 13G | Unicycive Therapeutics, Inc. UNCY | Walleye Capital LLC | 500,000 5.300% | 500,000 (New Position) | Filing History |